Quantitative immunohistochemistry in lung cancer: clinical perspective.
Quantitative immunohistochemistry remains an important tool in translational lung cancer research with hopes to improve patient outcomes and avoid unnecessary therapies. Present review is aimed to summarize the use of immunohistochemical markers for improved prognostic information and prediction of...
Main Authors: | Rafał Dziadziuszko, Ewa Szutowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Via Medica
2010-06-01
|
Series: | Folia Histochemica et Cytobiologica |
Online Access: | http://czasopisma.viamedica.pl/fhc/article/view/4252 |
Similar Items
-
Update on Immunohistochemistry for the Diagnosis of Lung Cancer
by: Kentaro Inamura
Published: (2018-03-01) -
Overview of Multiplex Immunohistochemistry and Immunofluorescence Techniques
in the Lung Cancer Immunotherapy
by: Wenjia SUN, et al.
Published: (2021-01-01) -
Expression and Clinical Significance of Cancer-derived Immunoglobulin G in Non-small Cell Lung Cancer by Bioinformatics and Immunohistochemistry
by: Guohui WANG, et al.
Published: (2019-06-01) -
Analysis of PAX8 immunohistochemistry in lung cancers: a meta-analysis
by: Jae Han Jeong, et al.
Published: (2020-07-01) -
Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
by: Eleni Gkika, et al.
Published: (2020-08-01)